Clinical Trials Browser

Pancreatic Ductal Adenocarcinoma × Immunotherapy × Clear all

NCT05955157 2024-01-10

Combined S-1 With DC+CIK As Maintenance Therapy For Advanced Pancreatic Ductal Adenocarcinoma

Phase 2/3 Unknown

GastrointestinalOther solid neoplasm

Pancreatic Ductal Adenocarcinoma